MEDICINA
Departamento
Guy's Hospital
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de Guy's Hospital (21)
2024
-
Embolization of percutaneous left atrial appendage closure devices: timing, management and clinical outcomes
Cardiovascular Revascularization Medicine
-
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)
Transplantation and Cellular Therapy, Vol. 30, Núm. 1, pp. 93.e1-93.e12
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 42-53
-
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
The Lancet, Vol. 401, Núm. 10373, pp. 269-280
2022
-
Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 8, pp. 2039-2051
-
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 8, pp. 1999-2012.e6
-
Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 8, pp. 2025-2038.e1
2021
-
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 6, pp. 2139-2144
-
Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosis
American Journal of Human Genetics, Vol. 108, Núm. 2, pp. 284-294
-
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference
Journal of Allergy and Clinical Immunology
-
Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19
New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802
2019
-
Current gaps in sepsis immunology: new opportunities for translational research
The Lancet Infectious Diseases, Vol. 19, Núm. 12, pp. e422-e436
2018
2017
2016
-
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; The American Academy of Allergy, Asthma & Immunology; And the European Academy of Allergology and Clinical Immunology
Journal of Allergy and Clinical Immunology, Vol. 137, Núm. 1, pp. 35-45
-
Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with Psoriasis
Journal of Investigative Dermatology, Vol. 136, Núm. 3, pp. 593-602
2014
-
Proposed diagnostic algorithm for patients with suspected mastocytosis: A proposal of the European Competence Network on Mastocytosis
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 69, Núm. 10, pp. 1267-1274
-
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): A consensus proposal
Annals of Oncology, Vol. 25, Núm. 9, pp. 1691-1700
2012
-
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives
Wiener Klinische Wochenschrift, Vol. 124, Núm. 23-24, pp. 807-814